AngloGold Ashanti's 2025 Revenue Surge Highlights Peak-Cycle Valuation Risks

What happened

AngloGold Ashanti reported a 72% year-over-year surge in 2025 revenues to $9.73 billion, driven by a 16% increase in gold production and higher metal prices, as noted in a recent Zacks article. This performance aligns with the DeepValue report's findings of strong operational momentum, including record free cash flow and production growth through 2025. However, the stock has skyrocketed 280% over the past year to $106, trading at peak-cycle multiples of 24x P/E and 21x EV/EBITDA, which the report flags as overvalued given current gold prices. The report further cautions that all-in sustaining costs and sustaining capex are drifting higher, limiting margin expansion and increasing downside exposure if gold prices or execution falter. Despite the revenue boost, the market sentiment is crowded with bullish consensus, underscoring the need for critical assessment of future growth and cost pressures.

Implication

The revenue growth confirms operational strength but does not address the DeepValue report's concerns about peak-cycle valuation and limited upside. With the stock trading at elevated multiples, earnings growth is likely to slow as production plateaus and costs increase, potentially leading to multiple compression. The variable dividend policy, tied to 50% of free cash flow, is pro-cyclical and may be cut if gold prices decline or capex rises, undermining income stability. Market sentiment is overly optimistic with crowded positions and high call-option activity, increasing vulnerability to a sentiment shift on any disappointment. Therefore, investors should consider trimming exposure, monitor 2026 guidance and dividend decisions closely, and wait for a better entry point or a gold price reset to reduce risk.

Thesis delta

The revenue announcement reinforces AngloGold Ashanti's operational success but does not alter the core thesis that the stock is overvalued at current levels. Investors should view this news as confirmation of peak-cycle performance rather than a catalyst for further upside, maintaining the recommendation to reduce exposure due to asymmetric risk/reward.